PubMed for id: 90903247

Year	Number of Results
1987	2
1988	1
1997	1
2005	1
2006	1
2023	2
2024	4

1

CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival.

Wedig J, Jasani S, Mukherjee D, Lathrop H, Matreja P, Pfau T, D'Alesio L, Guenther A, Fenn L, Kaiser M, Torok MA, McGue J, Sizemore GM, Noonan AM, Dillhoff ME, Blaser BW, Frankel TL, Culp S, Hart PA, Cruz-Monserrate Z, Mace TA. Wedig J, et al. Cancer Immunol Immunother. 2024 Apr 15;73(6):96. doi: 10.1007/s00262-024-03678-6. Cancer Immunol Immunother. 2024. PMID: 38619621 Free PMC article.

2

CD200 genotype is associated with clinical outcome of patients with multiple myeloma.

Gonzalez-Montes Y, Osca-Gelis G, Rodriguez-Romanos R, Villavicencio A, González-Bártulos M, Llopis F, Clapes V, Oriol A, Sureda A, Escoda L, Sarrà J, Garzó A, Lloveras N, Gómez B, Granada I, Gallardo D. Gonzalez-Montes Y, et al. Front Immunol. 2024 Feb 22;15:1252445. doi: 10.3389/fimmu.2024.1252445. eCollection 2024. Front Immunol. 2024. PMID: 38455039 Free PMC article.

3

Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200.

Moon SY, Han M, Ryu G, Shin SA, Lee JH, Lee CS. Moon SY, et al. Int J Mol Sci. 2023 Oct 11;24(20):15072. doi: 10.3390/ijms242015072. Int J Mol Sci. 2023. PMID: 37894750 Free PMC article. Review.

4

Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Alzheimer's disease.

Zhang M, Qian XH, Hu J, Zhang Y, Lin X, Hai W, Shi K, Jiang X, Li Y, Tang HD, Li B. Zhang M, et al. Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):455-467. doi: 10.1007/s00259-023-06446-3. Epub 2023 Oct 6. Eur J Nucl Med Mol Imaging. 2024. PMID: 37801139 Free PMC article.

5

Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.

Tang Y, Liu W, Kadu S, Johnson O, Hasanali ZS, Kelly A, Shestov A, Pajarillo R, Greenblatt E, Holmes M, Wang LP, Shih N, O'Connor RS, Ruella M, Garfall AL, Allman D, Vogl DT, Cohen A, June CH, Sheppard NC. Tang Y, et al. Blood. 2024 Jan 11;143(2):139-151. doi: 10.1182/blood.2022018658. Blood. 2024. PMID: 37616575 Free PMC article.

6

Cloning and characterization of the human CD200 promoter region.

Chen Z, Marsden PA, Gorczynski RM. Chen Z, et al. Mol Immunol. 2006 Feb;43(6):579-87. doi: 10.1016/j.molimm.2005.04.014. Epub 2005 Jun 13. Mol Immunol. 2006. PMID: 15955564

7

The leukocyte/neuron cell surface antigen OX2 binds to a ligand on macrophages.

Preston S, Wright GJ, Starr K, Barclay AN, Brown MH. Preston S, et al. Eur J Immunol. 1997 Aug;27(8):1911-8. doi: 10.1002/eji.1830270814. Eur J Immunol. 1997. PMID: 9295026

8

The gene for MRC OX-2 membrane glycoprotein is localized on human chromosome 3.

McCaughan GW, Clark MJ, Hurst J, Grosveld F, Barclay AN. McCaughan GW, et al. Immunogenetics. 1987;25(2):133-5. doi: 10.1007/BF00364281. Immunogenetics. 1987. PMID: 3817906 No abstract available.

9

Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein.

McCaughan GW, Clark MJ, Barclay AN. McCaughan GW, et al. Immunogenetics. 1987;25(5):329-35. doi: 10.1007/BF00404426. Immunogenetics. 1987. PMID: 3032785

10

RFLP and mapping of human MOX-1 gene on chromosome 3.

Douglas J, Albertson DG, Barclay AN, Davis M, Rabbitts PH. Douglas J, et al. Nucleic Acids Res. 1988 Sep 26;16(18):9067. doi: 10.1093/nar/16.18.9067. Nucleic Acids Res. 1988. PMID: 2902568 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year